BeiGene to Present at Upcoming Investor Conferences
04 November 2022 - 10:00PM
Business Wire
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global
biotechnology company, today announced that the Company will
participate in two upcoming investor conferences:
- The 6th Annual Cowen IO Next Virtual Conference on Friday,
November 11, at 9:40 a.m. (ET); and
- The 13th Annual Jefferies Global Healthcare Conference in
London on Wednesday, November 16 at 11:25 a.m. (ET).
A live webcast can be accessed from the investors section of
BeiGene’s websites at https://ir.beigene.com,
https://hkexir.beigene.com and https://sseir.beigene.com. An
archived replay will be available for 90 days following the
event.
About BeiGene BeiGene is a global biotechnology company
that is developing and commercializing innovative and affordable
oncology medicines to improve treatment outcomes and access for far
more patients worldwide. With a broad portfolio, we are expediting
development of our diverse pipeline of novel therapeutics through
our internal capabilities and collaborations. We are committed to
radically improving access to medicines for far more patients who
need them. Our growing global team of more than 9,000 colleagues
spans five continents, with administrative offices in Beijing,
China; Cambridge, U.S.; and Basel, Switzerland. To learn more about
BeiGene, please visit www.beigene.com and follow us on Twitter at
@BeiGeneGlobal.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221104005187/en/
Investor Kevin Mannix +1-857-302-5189 ir@beigene.com
Media Kyle Blankenship +1 667-351-5176
media@beigene.com
BeiGene (NASDAQ:BGNE)
Historical Stock Chart
From Jun 2024 to Jul 2024
BeiGene (NASDAQ:BGNE)
Historical Stock Chart
From Jul 2023 to Jul 2024